RPS6KB1 and lung carcinoma: Consistent with the almost complete growth inhibition of diverse xenografts by Super-EBS, indicating the requirement for S6K1 in tumor growth, lung cancer cells knocked out for S6K1 by CRISPR/Cas9 targeting failed to grow tumors in mice.